Health News Releases

  • Today August 27
August 31, 2021 17:13
Vifor Pharma’s Ferinject® granted new recommendations in updated 2021 ESC heart failure guidelines
Regulatory News: Vifor Pharma is pleased to announce that the European Society of Cardiology (ESC) included new recommendations and proposals in the 2021 ESC guidelines for the diagnosis and treatm
August 31, 2021 14:00
Masimo SafetyNet Alert™ Launches in Western Europe
Masimo (NASDAQ: MASI) announced today the CE marking and launch in western Europe of Masimo SafetyNet Alert™, an arterial blood oxygen saturation monitoring and alert system designed for use at home.
August 30, 2021 10:30
Landmark trial demonstrates empagliflozin is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction
Full results from the landmark EMPEROR-Preserved Phase III trial demonstrated that empagliflozin showed an impressive 21 percent relative risk reduction for the composite primary endpoint of cardiovas
August 27, 2021 14:15
Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring
Masimo (NASDAQ: MASI) announced today the conclusions of a whitepaper published by the Society for the Advancement of Patient Blood Management (SABM) which highlights the importance of continuous hemo
August 26, 2021 17:40
RubrYc Therapeutics Announces Series A2 Preferred Equity Financing, Collaboration, and RTX-003 License with iBio, Inc.
RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of RubrYc’s Series A2 Preferred Financing, and concomitant License and Collaboration Agreements di
August 25, 2021 15:40
Adjuvance Technologies Announces First Clinical Results of its Next-generation Saponin Adjuvant
Adjuvance Technologies Inc., a privately held clinical-stage biopharmaceutical company developing saponin adjuvants and vaccines for infectious disease and immuno-oncology, announced that its adjuvant
August 24, 2021 14:50
Vifor Pharma and Cara Therapeutics announce U.S. FDA approval of KORSUVA™ injection for the treatment of moderate-to-severe pruritus in hemodialysis patients
Regulatory News: Vifor Pharma and Cara Therapeutics (Nasdaq:CARA) today announced that the U.S. Food and Drug Administration (FDA) has approved KORSUVA™ (difelikefalin) for injection for the treatm
August 24, 2021 10:50
New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients
Masimo (NASDAQ: MASI) announced today the findings of a study published in the Turkish Journal of Emergency Medicine in which Drs. Seda Dağar and Hüseyin Uzunosmanoğlu at the Kecioren Training and Res
August 23, 2021 10:00
ZOLL and Wallaby Medical Announce Agreement to Distribute Temperature Management Products in China
ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Wallaby Medical Technologies, a medical device company dedicated to treating str
August 18, 2021 11:00
SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have expanded their product line of research reagents for COVID-19 variant analysis to include a mutation connected to the S
August 17, 2021 14:09
Philip Morris International Enters Tender Period with Vectura Shareholders Following Unanimous Recommendation by Vectura Board
Philip Morris International Inc. (PMI) (NYSE: PM) today announced it has published an offer document with U.K.-based Vectura Group plc (Vectura) (LSE: VEC) in connection with the recommended cash offe
August 13, 2021 10:40
Rockley Photonics Announces Successful Closing of Business Combination with SC Health Corp.
Rockley Photonics, Ltd. (“the Company” or “Rockley”), a leading global silicon photonics technology company, today announced the completion of its business combination with SC Health Corp. (“SC Health
August 12, 2021 17:30
SpeeDx Receives Clearance for COVID-19 Diagnostic Test
SpeeDx Pty. Ltd. announced today their PlexPCR® SARS-CoV-2[*] test received clearance from the Australian Therapeutic Goods Administration (TGA). Designed from a database of over 1,000,000 sequences,
Siemens Korea holds ‘8th Smart NC Contest’ online… Recruiting participants from university and high
August 12, 2021 11:51
Siemens Korea Holds ‘8th Smart NC Contest’ Online… Recruiting Participants from University and High School Groups
Siemens Korea (Siemens Ltd. Seoul·SLS) calls for participants until September 1 for the ‘8th Smart NC(Numerical Control) Contest’ officially held on September 2. The Smart NC Contest, which marks i
August 10, 2021 11:20
Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics
Lightbeam Health Solutions, the leader in end-to-end population health management solutions and services, is proud to announce their partnership with Ambry Genetics, a Konica Minolta Precision Medicin
August 06, 2021 11:15
Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced the publication of the final results from the Phase 3 HELP (Hereditary Angioedema Long-term Prophylaxis) Study™ Op
August 05, 2021 16:30
Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance[1]
Regulatory News: Vifor Pharma Group reported profitable revenue growth in H1 supported by a strong recovery in Ferinject® / Injectafer® with sales up 22.8% at CER as a result of improved patient ac
August 04, 2021 11:00
Former World Economic Forum Member of the Managing Board Murat Sönmez Joins Avellino’s Board of Directors
Avellino Lab USA, Inc. (Avellino) today announced the appointment of Murat Sönmez to the company’s Board of Directors. Murat is a former World Economic Forum Member of the Managing Board and foundi
Frank Zimmermann, Senior Executive Vice President & CFO of Siemens Korea
August 04, 2021 10:58
Siemens appoints Frank Zimmermann as Senior Executive Vice President and CFO of Siemens Korea
Siemens announced the official appointment of Mr. Frank Zimmermann as Senior Executive Vice President & Chief Financial Officer (CFO) of Siemens Korea (Siemens Ltd. Seoul·SLS) effective August 1, 2021
August 03, 2021 17:22
First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
In the first half of 2021, Boehringer Ingelheim has supplied more humans and animals worldwide with innovative medicines than ever before. The company’s success is based on its rich R&D portfolio with
August 02, 2021 17:00
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the receipt of a decision by the Irish Tax Appeals Commission on July 30, 2021 (IST) to uphold the Irish Revenue Co
August 02, 2021 15:50
NIH Advances ACTIV-5/BET-B Trial Evaluating Lenzilumab from a Phase 2 Exploratory Study to a Phase 2/3 Study for the Treatment of COVID-19
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company developing a first-in-class GM-CSF neutralizing antibody to prevent and treat an immune hyper-response called ‘
August 02, 2021 13:40
ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results from Two on-going Phase 2a Studies in Chronic Hepatitis B Patients
ENYO Pharma (ENYO), a private clinical stage biotechnology company developing innovative drug candidates, today announced positive proof of concept data from Study EYP001-203 of Vonafexor in combinati
August 02, 2021 13:30
Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced financial results for the first quarter of fiscal year 2021 (period ended June 30, 2021). Based on the solid firs
July 30, 2021 15:30
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceutical co
25 per page50 per page75 per page100 per page